FTC - Federal Trade Commission

01/30/2026 | Press release | Archived content

The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group[...]

Last Updated
January 30, 2026
Case Status
Pending
In the Matter of Caremark Rx, LLC; Zinc Health Services LLC; Express Scripts, Inc.; Evernorth Health, Inc.; Medco Health Services, Inc.; Ascent Health Services LLC; OptumRx, Inc.; OptumRx Holdings LLC; and Emisar Pharma Services LLC, Respondents
FTC Matter/File Number
221 0114
Docket Number
9437
Enforcement Type
Part 3 Administrative Complaints

Case Summary

The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)-Caremark Rx, Express Scripts (ESI), and OptumRx-and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.

Case Timeline

January 30, 2026
File
January 21, 2026
January 20, 2026
January 15, 2026
File
January 14, 2026
January 13, 2026
January 8, 2026
January 2, 2026
December 12, 2025
December 10, 2025
December 8, 2025
November 13, 2025
September 24, 2025
September 23, 2025
August 28, 2025
File
August 27, 2025
August 18, 2025
August 14, 2025
May 30, 2025
April 1, 2025
February 20, 2025
December 23, 2024
December 18, 2024
December 3, 2024
October 11, 2024
October 8, 2024
October 7, 2024
September 24, 2024
FTC - Federal Trade Commission published this content on January 30, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 02, 2026 at 14:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]